Stockscreener 앱 받기
2.32
7.20%
-0.18
시장 영업 전:
2.31
-0.010
-0.43%
전일 마감가:
$2.50
열려 있는:
$2.47
하루 거래량:
136.31K
Relative Volume:
0.08
시가총액:
$109.34M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-6.83%
1개월 성능:
+4.04%
6개월 성능:
+13.73%
1년 성능:
+0.00%
1일 변동 폭
$2.24
$2.54
1주일 범위
$2.24
$2.63
52주 변동 폭
$1.39
$3.7699
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
명칭
Whitehawk Therapeutics Inc
전화
551-321-2234
주소
2 HEADQUARTERS PLAZA, MORRISTOWN
WHWK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
2.32 | 117.82M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-27 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-08-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-08-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-01-11 | 개시 | Jefferies | Buy |
| 2021-10-01 | 개시 | Cowen | Outperform |
| 2021-09-14 | 개시 | Ladenburg Thalmann | Buy |
| 2021-09-08 | 개시 | Piper Sandler | Overweight |
모두보기
Whitehawk Therapeutics Inc 주식(WHWK)의 최신 뉴스
Bond Watch: Is Whitehawk Therapeutics Inc stock a top pick in earnings seasonMarket Sentiment Review & Entry Point Strategy Guides - moha.gov.vn
Financial Comparison: Whitehawk Therapeutics (NASDAQ:WHWK) vs. BetterLife Pharma (OTCMKTS:PVOTF) - Defense World
Shorts Report: What risks investors should watch in Whitehawk Therapeutics Inc stockExit Point & Smart Investment Allocation Tips - moha.gov.vn
Will Whitehawk Therapeutics Inc. (3350) stock profit from automation waveStop Loss & Daily Stock Trend Reports - Newser
What makes Whitehawk Therapeutics Inc. stock attractive to growth fundsJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Is Whitehawk Therapeutics Inc. (3350) stock worth buying before Fed actionAnalyst Upgrade & Capital Efficient Trading Techniques - Newser
Comparing Whitehawk Therapeutics (NASDAQ:WHWK) & Acerus Pharmaceuticals (OTCMKTS:TRLPF) - Defense World
How Whitehawk Therapeutics Inc. stock performs in stagflationJuly 2025 Retail & Safe Capital Investment Plans - Newser
How Whitehawk Therapeutics Inc. stock compares to market leadersJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser
Why Whitehawk Therapeutics Inc. (3350) stock stays resilientWeekly Gains Report & Expert Approved Trade Ideas - Newser
Can Whitehawk Therapeutics Inc. stock beat analyst upgradesJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Will Whitehawk Therapeutics Inc. (3350) stock benefit from commodity supercycleJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - Newser
How Whitehawk Therapeutics Inc. (3350) stock compares with top peersJuly 2025 Trade Ideas & Stock Portfolio Risk Management - Newser
What analysts say about Whitehawk Therapeutics Inc 3350 stockValue Stock Picks & Free Stock Trading Workshops - earlytimes.in
How Whitehawk Therapeutics Inc. (3350) stock trades after earnings2025 Risk Factors & Safe Capital Growth Trade Ideas - Newser
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - citybiz
Whitehawk therapeutics names Margaret Dugan as chief medical officer - Investing.com
Whitehawk Therapeutics appoints Margaret Dugan as chief medical officer - marketscreener.com
Whitehawk therapeutics names Margaret Dugan as chief medical officer By Investing.com - Investing.com Australia
Whitehawk Therapeutics Appoints Margaret Dugan, As Chief Medical Officer - TradingView
Published on: 2025-11-30 18:46:11 - BỘ NỘI VỤ
What risks investors should watch in Whitehawk Therapeutics Inc. stockQuarterly Earnings Report & Short-Term High Return Ideas - BỘ NỘI VỤ
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress
Whitehawk Therapeutics (Nasdaq: WHWK) at Piper Sandler 37th Conference on Dec. 3 - Stock Titan
What analysts say about Whitehawk Therapeutics Inc stockSupport Level Holds & High Return Capital Gain - earlytimes.in
Is Whitehawk Therapeutics Inc. stock positioned well for digital economyWeekly Gains Report & Verified Swing Trading Watchlist - newser.com
Whitehawk Therapeutics stock holds steady as Jefferies maintains rating By Investing.com - Investing.com Canada
Whitehawk Therapeutics stock holds steady as Jefferies maintains rating - Investing.com
Can Whitehawk Therapeutics Inc. (3350) stock withstand sector downturnsAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Will Whitehawk Therapeutics Inc. (3350) stock deliver stable dividends2025 Biggest Moves & AI Driven Stock Reports - newser.com
Multi asset correlation models including Whitehawk Therapeutics Inc.July 2025 Catalysts & Weekly Momentum Picks - newser.com
Published on: 2025-11-19 15:47:46 - newser.com
Candlestick signals on Whitehawk Therapeutics Inc. stock today2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Smart tools for monitoring Whitehawk Therapeutics Inc.’s price actionMarket Rally & Advanced Technical Signal Analysis - newser.com
How Whitehawk Therapeutics Inc. stock performs after earningsRate Cut & Long-Term Capital Growth Strategies - newser.com
Whitehawk Therapeutics Inc (WHWK) 재무 분석
Whitehawk Therapeutics Inc (WHWK)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):